These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10487795)

  • 1. Lipids and coronary restenosis:an elusive link.
    de Feyter PJ
    Eur Heart J; 1999 Oct; 20(19):1371-4. PubMed ID: 10487795
    [No Abstract]   [Full Text] [Related]  

  • 2. Relation of lumen size to restenosis after percutaneous transluminal coronary balloon angioplasty. Lovastatin Restenosis Trial Group.
    Waksman R; Kosinski AS; Klein L; Boccuzzi SJ; King SB; Ghazzal ZM; Weintraub WS
    Am J Cardiol; 1996 Jul; 78(2):221-4. PubMed ID: 8712148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of statins in primary prevention: from the theoretical presuppositions to complex scenarios of the real world].
    Poli A; Menotti A
    G Ital Cardiol; 1999 Oct; 29(10):1123-30. PubMed ID: 10546121
    [No Abstract]   [Full Text] [Related]  

  • 4. Lovastatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplasty.
    O'Keefe JH; Stone GW; McCallister BD; Maddex C; Ligon R; Kacich RL; Kahn J; Cavero PG; Hartzler GO; McCallister BD
    Am J Cardiol; 1996 Mar; 77(8):649-52. PubMed ID: 8610621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luminal loss and restenosis after coronary angioplasty. The role of lipoproteins and lipids.
    Jorgensen B; Simonsen S; Endresen K; Forfang K; Egeland T; Høstmark AT; Thaulow E
    Eur Heart J; 1999 Oct; 20(19):1407-14. PubMed ID: 10487801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New strategies in the treatment of restenosis].
    von Hodenberg E; Tost B; Scheffold T
    Z Kardiol; 2000; 89 Suppl 7():19-22. PubMed ID: 11098555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lovastatin to prevent acute coronary events with average cholesterol levels.
    MacFarlane LL; Carek PJ
    J Fam Pract; 1998 Aug; 47(2):91-2. PubMed ID: 9722787
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reduction in the rates of restenosis after coronary angioplasty with simvastatin and probucol].
    Merchán Herrera A; López Mínguez JR; Alonso Ruiz F; Escola JM; Címbora Ortega A; Poblador Curto MA; Redondo Méndez A; Romero Santisteban R; Geniz Gallardo I; González Fernández R; Millán Núñez V
    Rev Esp Cardiol; 1999 Oct; 52(10):778-84. PubMed ID: 10563153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can aggressive efforts directed at lipid lowering post-PTCA reduce the risk of restenosis?
    Drown DJ
    Prog Cardiovasc Nurs; 1995; 10(2):40. PubMed ID: 7651950
    [No Abstract]   [Full Text] [Related]  

  • 10. [The "healthy" patient with hypercholesterolemia].
    Klose G
    Med Klin (Munich); 2005 Feb; 100(2):99-106; quiz 107-8. PubMed ID: 15711905
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipoprotein (a) is not a risk factor for restenosis after percutaneous transluminal coronary angioplasty.
    Schumacher M; Tiran A; Eber B; Toplak H; Wilders-Truschnig M; Klein W
    Am J Cardiol; 1992 Feb; 69(5):572. PubMed ID: 1531283
    [No Abstract]   [Full Text] [Related]  

  • 12. [Despite coronary intervention, the risk remains high: PCI patients need additional protection].
    MMW Fortschr Med; 2004 Jun; 146(24):3. PubMed ID: 15366508
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of serum cholesterol and cholesterol subfractions on restenosis following successful coronary intervention.
    Violaris AG; Ismail TF; El-Gendi H; Foale RA
    Semin Interv Cardiol; 1999 Sep; 4(3):111-9. PubMed ID: 10545617
    [No Abstract]   [Full Text] [Related]  

  • 15. [Stable ischemic coronary disease--medical therapy or PCI?].
    Mickley H; Egstrup K
    Ugeskr Laeger; 2007 Jun; 169(23):2227. PubMed ID: 17607849
    [No Abstract]   [Full Text] [Related]  

  • 16. Avoid angioplasty by lowering cholesterol?
    Health News; 1999 Aug; 5(10):5. PubMed ID: 15352287
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of serum lipid concentrations on restenosis after successful de novo percutaneous transluminal coronary angioplasty in patients with total cholesterol 160 to 240 mg/dl and triglycerides < 350 mg/dl.
    Dzavik V; Teo KK; Yokoyama S; Modi R; Dinwoodie A; Burton JR; Tymchak WJ; Montague TJ
    Am J Cardiol; 1995 May; 75(14):936-8. PubMed ID: 7733005
    [No Abstract]   [Full Text] [Related]  

  • 18. [Substantiation of increasing doses of statins in clinical practice].
    Susekov AV
    Ter Arkh; 2001; 73(4):76-80. PubMed ID: 11494456
    [No Abstract]   [Full Text] [Related]  

  • 19. [Stable coronary heart disease--lessons from the COURAGE Study. With intensive drug therapy on the success track].
    MMW Fortschr Med; 2008 Jun; 150(23):38-9. PubMed ID: 18575368
    [No Abstract]   [Full Text] [Related]  

  • 20. [Can radiotherapy reduce the frequency of restenosis after coronary angioplasty?].
    Langberg CW; Solheim S; Hagen S
    Tidsskr Nor Laegeforen; 2000 Feb; 120(6):707-10. PubMed ID: 10806885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.